TRIM21 and interstitial lung disease: Recent investigations have increasingly focused on anti‐Ro52 Abs, demonstrating their independent association with ILD across various connective tissue diseases [31], their potential as biomarkers for pulmonary involvement in SSc [32], and their identification as a risk factor for PH among SSc patients [33].